Medicinova, Inc. (MNOV) is a publicly traded Healthcare sector company. As of July 26, 2026, MNOV trades at $1.32 with a market cap of $64.97M and a P/E ratio of -5.83. MNOV moved +0.00% today. Year to date, MNOV is +0.76%; over the trailing twelve months it is +6.45%. Its 52-week range spans $1.13 to $2.48. Analyst consensus is buy with an average price target of $8.00. Rallies surfaces MNOV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest MNOV news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $1.32 |
| Market Cap | $64.97M |
| P/E Ratio | -5.83 |
| EPS | $-0.23 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.48 |
| 52-Week Low | $1.13 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $596.64K |
| Net Income | $-11.72M |
| Gross Margin | 0.00% |
2 analysts cover MNOV: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $8.00.